Contrasting Quhuo (NASDAQ:QH) & Augmedix (NASDAQ:AUGX)

Augmedix (NASDAQ:AUGX) and Quhuo (NASDAQ:QH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and earnings.

Institutional & Insider Ownership

87.1% of Augmedix shares are held by institutional investors. Comparatively, 0.2% of Quhuo shares are held by institutional investors. 11.0% of Augmedix shares are held by company insiders. Comparatively, 33.1% of Quhuo shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Augmedix and Quhuo’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Augmedix	-46.23%	-182.36%	-43.21%
Quhuo	N/A	N/A	N/A

Risk and Volatility

Augmedix has a beta of -0.22, suggesting that its stock price is 122% less volatile than the S&P 500. Comparatively, Quhuo has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Augmedix and Quhuo, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Augmedix	0	4	0	0	2.00
Quhuo	0	0	0	0	N/A

Augmedix currently has a consensus price target of $3.09, suggesting a potential upside of 32.51%. Given Augmedix’s higher possible upside, equities research analysts plainly believe Augmedix is more favorable than Quhuo.

Earnings & Valuation

This table compares Augmedix and Quhuo”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Augmedix	$51.58 million	2.21	-$19.17 million	($0.43)	-5.42
Quhuo	$521.47 million	0.01	$470,000.00	N/A	N/A

Quhuo has higher revenue and earnings than Augmedix.

Summary

Quhuo beats Augmedix on 7 of the 10 factors compared between the two stocks.

About Augmedix

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

About Quhuo

Quhuo Limited, through its subsidiaries, operates a workforce operational solution platform in the People's Republic of China. It provides tech-enabled and end-to-end operational solutions to on-demand consumer service businesses in industries, including food and grocery delivery, bike-sharing, ride-hailing, and housekeeping. The company also offers ride hailing solutions for ride-hailing companies; housekeeping solutions and other services for short-term rental properties and hotel cleaning services; and shared-bike maintenance solutions to address the demand for maintenance and distribution services from bike-sharing companies, as well as freight services. In addition, it engages in the development of computer software and applications; and investment holding activities. The company was founded in 2012 and is based in Beijing, the People's Republic of China.